Balanol

Balanol

SCHEMBL12012990

O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 20/20 1.00
PRKCA P17252 20/20 1.00
PRKCE Q02156 19/20 1.00
PRKCG P05129 17/20 1.00
PRKCH P24723 17/20 1.00
PRKCD Q05655 17/20 1.00
PRKACA P17612 14/20 1.00
PRKACG P22612 10/20 1.00
PRKACB P22694 10/20 1.00
PRKCZ Q05513 9/20 1.00
PRKD3 O94806 3/20 1.00
PRKCI P41743 3/20 1.00
PRKCQ Q04759 3/20 1.00
PRKD1 Q15139 3/20 1.00
GRK2 P25098 1/20 1.00
GRK4 P32298 1/20 1.00
GRK5 P34947 1/20 1.00
GRK3 P35626 1/20 1.00
GRK6 P43250 1/20 1.00
PRKG1 Q13976 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Balanol SCHEMBL62128 1.00 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL62129 1.00 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL8666687 0.99 PRKCB (0.98) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9196065 0.97 PRKCB (0.94) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9198287 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9198347 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
Balanol SCHEMBL9393094 0.95 PRKCB (0.91) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL14515466 0.94 PRKCB (1.00) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL17251291 0.93 PRKCB (0.87) PRKCBPRKCAPRKCEPRKCGPRKCH
SCHEMBL9396551 0.92 PRKCB (0.86) PRKCBPRKCAPRKCEPRKCGPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10485845-B2 Neuronal pain pathway THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-11-26 US disclosed
US-9402826-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-02 US disclosed
US-9402826-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-02 US disclosed
US-20150320761-A1 NEURONAL PAIN PATHWAY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-11-12 US disclosed
US-9107868-B2 Neuronal pain pathway THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-08-18 US disclosed
US-9107868-B2 Neuronal pain pathway THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-08-18 US disclosed
US-20150126576-A1 NEURONAL PAIN PATHWAY MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-05-07 US disclosed
US-20150126576-A1 NEURONAL PAIN PATHWAY MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-05-07 US disclosed
US-8846742-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-09-30 US disclosed
US-8846742-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-09-30 US disclosed
US-20120295853-A1 NEURONAL PAIN PATHWAY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-11-22 US disclosed
US-20120295853-A1 NEURONAL PAIN PATHWAY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-11-22 US disclosed
US-8252754-B2 Neuronal pain pathway THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-08-28 US disclosed
US-8252754-B2 Neuronal pain pathway THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-08-28 US disclosed
US-20080176920-A1 protein kinase G inhibitors; analogs of balanol THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2008-07-24 US disclosed
US-20080176920-A1 protein kinase G inhibitors; analogs of balanol THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2008-07-24 US disclosed
WO-2007095586-A2 NEURONAL PAIN PATHWAY MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126576-A1 NEURONAL PAIN PATHWAY MODULATORS GRIN3A, GRIN3B, OPRK1 PRKCB 187/4885PRKCA 170/4885PRKCE 276/4885
US-20080176920-A1 protein kinase G inhibitors; analogs of balanol PRKCG, GRK3, PRKG1 PRKCB 27/4885PRKCA 16/4885PRKCE 25/4885
US-20120295853-A1 NEURONAL PAIN PATHWAY PRKG1, PRKG2, MAP4K2 PRKCB 43/4885PRKCA 42/4885PRKCE 79/4885
US-10485845-B2 Neuronal pain pathway PRKG1, PRKG2, MAP4K2 PRKCB 43/4885PRKCA 42/4885PRKCE 79/4885
US-20150320761-A1 NEURONAL PAIN PATHWAY PRKG1, PRKG2, MAP4K2 PRKCB 43/4885PRKCA 42/4885PRKCE 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.